Monroe backs Altaris Capital’s buyout of Kindeva

Monroe Capital has provided funding to back Altaris Capital Partners' acquisition of Kindeva Drug Delivery LP.

To view this content, you need to sign in.


You should only be asked to sign in once. Not the case? Click here


Register now to access this content and more for free.

Share this